detect and diagnose early-stage cancers, identify metastases noninvasively, and guide tumor removal during surgery. For image-guided surgery, the use of targeted nanoparticles to identify lesions has been an active area of investigation. In general
Search Results
Stephanie A. Morris, Dorothy Farrell, and Piotr Grodzinski
Elizabeth R. Kessler, Janet B. Kukreja, Christopher L. Geiger, and Stacy M. Fischer
validated tools ( Table 1 ). Multiple studies have found that the CGA is more sensitive than performance status in determining functional impairment and risks associated with chemotherapy or surgery. 5 The CGA can uncover age-related issues in up to 50% of
Yue Chen, Zi-Qi Zheng, Fo-Ping Chen, Jian-Ye Yan, Xiao-Dan Huang, Feng Li, Ying Sun, and Guan-Qun Zhou
, accounting for 25% of malignant tumors in the major salivary glands and 50% in the minor glands. 2 The natural disease process is characterized by prolonged progression and multiple recurrences. 3 , 4 Surgery has been considered the most important treatment
Karam Khaddour, Michael R. Chicoine, Jiayi Huang, Sonika Dahiya, and George Ansstas
squamous epithelial cells (original magnification, ×20). At his follow-up visit 5 months after the surgery, the patient continued to have persistent headaches and peripheral vision loss, but they were milder than the initial symptoms reported before surgery
Pankaj Singhal and Shashikant Lele
Gynecologic Oncology Group study . J Clin Oncol 2003 ; 21 : 3194 – 3200 . 4. Hoskins WJ McGuire WP Brady MF . The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual
Patrick Ross Jr
“Photodynamic therapy (PDT) is not just a palliative treatment,” declared Patrick Ross, Jr, MD, PhD, Director, Division of Thoracic Surgery, The Ohio State University (OSU), Columbus, Ohio. “The real bang for the buck with PDT has got to be
Matthew E. Nielsen, Bruce J. Trock, and Patrick C. Walsh
untreated and most will die of prostate cancer. 2 The argument for postoperative radiotherapy (RT) is predicated on the assumption that some patients may have residual local disease of a potentially lethal phenotype after surgery and that the delivery of
Yvonne H. Sada, Brandon G. Smaglo, Joy C. Tan, Hop S. Tran Cao, Benjamin L. Musher, and Nader N. Massarweh
Background Gastric cancer is the fifth most common cancer and second leading cause of cancer-related death globally. 1 Despite improved survival outcomes with multimodality treatment (MMT) compared with surgery alone, nearly half of patients who
Lindsay J. Collin, Ming Yan, Renjian Jiang, Keerthi Gogineni, Preeti Subhedar, Kevin C. Ward, Jeffrey M. Switchenko, Joseph Lipscomb, Jasmine Miller-Kleinhenz, Mylin A. Torres, Jolinta Lin, and Lauren E. McCullough
women had information available for assigning tumor subtype (ER, the progesterone receptor used to define women as hormone receptor–positive [HR+] or hormone receptor–negative [HR–], and HER2 expression) and had received surgery as part of their local
Julie Hallet, Laura Davis, Alyson Mahar, Michail Mavros, Kaitlyn Beyfuss, Ying Liu, Calvin H.L. Law, Craig Earle, and Natalie Coburn
cancer surgery. 1 – 3 This finding has impacted policy through implementation of regionalized care networks for surgery. 4 – 9 Beyond surgical therapy, patient volume for nonsurgical interventions may be important to consider in the delivery of high